Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024. https://gco.iarc.who.int/today.

ECIS. ECIS - European Cancer Information System; 2025. https://ecis.jrc.ec.europa.eu/.

REDECAN. Red Española de Registros de Cáncer. La prevalencia del cáncer en España a 31–12–2020; 2021. https://redecan.org/es/proyectos/10/la-prevalencia-del-cancer-en-espana-a-31-12-2020.

OECD/European Commission. EU Country Cancer Profile: Spain 2025, EU Country Cancer Profiles, OECD Publishing, Paris; 2025. https://doi.org/10.1787/1f6a5051-en.

Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356:227–36.

Article  CAS  PubMed  Google Scholar 

Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6:798–808.

Article  PubMed  Google Scholar 

Bodewes FTH, van Asselt AA, Dorrius MD, Greuter MJW, de Bock GH. Mammographic breast density and the risk of breast cancer: a systematic review and meta-analysis. Breast. 2022;66:62–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bissell MCS, Kerlikowske K, Sprague BL, Tice JA, Gard CC, Tossas KY, et al. Breast cancer population attributable risk proportions associated with body mass index and breast density by race/ethnicity and menopausal status. Cancer Epidemiol Biomarkers Prev. 2020;29:2048–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huo CW, Chew GL, Britt KL, Ingman WV, Henderson MA, Hopper JL, et al. Mammographic density-a review on the current understanding of its association with breast cancer. Breast Cancer Res Treat. 2014;144:479–502.

Article  CAS  PubMed  Google Scholar 

Ye D-M, Yu T. The epidemiologic factors associated with breast density: a review. J Res Med Sci. 2022;27:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaudet MM, Gierach GL, Carter BD, Luo J, Milne RL, Weiderpass E, et al. Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype. Cancer Res. 2018;78:6011–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.

Article  CAS  PubMed  Google Scholar 

Shawky MS, Huo CW, Henderson MA, Redfern A, Britt K, Thompson EW. A review of the influence of mammographic density on breast cancer clinical and pathological phenotype. Breast Cancer Res Treat. 2019;177:251–76.

Article  PubMed  Google Scholar 

Antoni S, Sasco AJ, dos Santos Silva I, McCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat. 2013;137:337–47.

Article  PubMed  Google Scholar 

Bai S, Song D, Chen M, Lai X, Xu J, Dong F. The association between mammographic density and breast cancer molecular subtypes: a systematic review and meta-analysis. Clin Radiol. 2023;78:622–32.

Article  CAS  PubMed  Google Scholar 

Li E, Guida JL, Tian Y, Sung H, Koka H, Li M, et al. Associations between mammographic density and tumor characteristics in Chinese women with breast cancer. Breast Cancer Res Treat. 2019;177:527–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian Y, Guida JL, Koka H, Li E-N, Zhu B, Sung H, et al. Quantitative mammographic density measurements and molecular subtypes in chinese women with breast cancer. JNCI Cancer Spectr. 2021;5:pkaa092.

Article  PubMed  Google Scholar 

Shieh Y, Scott CG, Jensen MR, Norman AD, Bertrand KA, Pankratz VS, et al. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Res. 2019;21:48.

Article  PubMed  PubMed Central  Google Scholar 

Kleinstern G, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Bertrand KA, et al. Association of mammographic density measures and breast cancer “intrinsic” molecular subtypes. Breast Cancer Res Treat. 2021;187:215–24.

Article  PubMed  PubMed Central  Google Scholar 

McCarthy AM, Friebel-Klingner T, Ehsan S, He W, Welch M, Chen J, et al. Relationship of established risk factors with breast cancer subtypes. Cancer Med. 2021;10:6456–67.

Article  PubMed  PubMed Central  Google Scholar 

Pollán M, Llobet R, Miranda-García J, Antón J, Casals M, Martínez I, et al. Validation of DM-scan, a computer-assisted tool to assess mammographic density in full-field digital mammograms. Springerplus. 2013;2:242.

Article  PubMed  PubMed Central  Google Scholar 

Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:e48-72.

Article  CAS  PubMed  Google Scholar 

Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2013;31:3997–4013.

Article  Google Scholar 

Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology/college of American pathologists clinical practice guideline focused update. Arch Pathol Lab Med. 2018;142:1364–82.

Article  PubMed  Google Scholar 

Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160:301–5.

Article  PubMed  Google Scholar 

Localio AR, Margolis DJ, Berlin JA. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression. J Clin Epidemiol. 2007;60:874–82.

Article  PubMed  Google Scholar 

Edwards BL, Atkins KA, Stukenborg GJ, Novicoff WM, Larson KN, Cohn WF, et al. The association of mammographic density and molecular breast cancer subtype. Cancer Epidemiol Biomarkers Prev. 2017;26:1487–92.

Article  PubMed  Google Scholar 

Kumar N, Ehsan S, Banerjee S, Perez CF, Lhuilier I, Neuner J, et al. The associations of breast density, hormone use, family history, reproductive, and lifestyle factors with triple-negative breast cancer: a systematic review and meta-analysis; 2023. https://doi.org/10.2139/ssrn.4567979

Shin J, Lee JE, Ko HY, Nguyen TL, Nam SJ, Hopper JL, et al. Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study. Eur J Cancer Prev. 2018;27:239–47.

Article  CAS  PubMed  Google Scholar 

Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:479–85.

Article  CAS  PubMed  Google Scholar 

Pollán M, Ascunce N, Ederra M, Murillo A, Erdozáin N, Alés-Martínez J, et al. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res. 2013;15:R9.

Article  PubMed  PubMed Central  Google Scholar 

Archer M, Dasari P, Evdokiou A, Ingman WV. Biological mechanisms and therapeutic opportunities in mammographic density and breast cancer risk. Cancers. 2021;13:5391.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ironside AJ, Jones JL. Stromal characteristics may hold the key to mammographic density: the evidence to date. Oncotarget. 2016;7:31550–62.

Article  PubMed  PubMed Central  Google Scholar 

Radenkovic S, Konjevic G, Gavrilovic D, Stojanovic-Rundic S, Plesinac-Karapandzic V, Stevanovic P, et al. PSTAT3 expression associated with survival and mammographic density of breast cancer patients. Pathol Res Pract. 2019;215:366–72.

Article  CAS  PubMed